Evidence map›Paper›PMID 35870365›Full record

Observational studyRespiratory medicine and research2022

Clinical outcomes and lung ultrasound findings in COVID-19 follow up: Calm comes after the storm?

Nikita Gurbani, Marco Acosta-Sorensen, David Díaz-Pérez, Juan Marco Figueira-Goncalves, Yolanda Ramallo-Fariña, José Luis Trujillo-Castilla

Open access · greenAbstract readObservational Study
In one paragraph

Observational study in Respiratory medicine and research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Post-COVID-19 dyspnoea and pulmonary imaging: a systematic review and meta-analysis.European respiratory review : an official journal of the European Respiratory Society · 2023
    Pooled it
  2. Article
  3. Observational
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Nikita GurbaniRespiratory Medicine and Thoracic Surgery Department, Guy's and St Thomas NHS Foundation Trust, University Hospital Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain. Electronic address: Nikita.gurbani@nhs.net.
Marco Acosta-SorensenRespiratory Medicine and Thoracic Surgery Department, Guy's and St Thomas NHS Foundation Trust, University Hospital Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain.
David Díaz-PérezRespiratory Medicine and Thoracic Surgery Department, Guy's and St Thomas NHS Foundation Trust, University Hospital Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain.
Juan Marco Figueira-GoncalvesRespiratory Medicine and Thoracic Surgery Department, Guy's and St Thomas NHS Foundation Trust, University Hospital Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain; Instituto Universitario de Enfermedades Tropicales y Salud Publica de Canarias, Universidad de La Laguna, Santa Cruz de Tenerife, Spain.
Yolanda Ramallo-FariñaCanary Islands Health Research Institute Foundation (FIISC), Tenerife, ES, Spain; Research Network on Health Services in Chronic Diseases (REDISSEC), ES, Madrid, Spain.
José Luis Trujillo-CastillaRespiratory Medicine and Thoracic Surgery Department, Guy's and St Thomas NHS Foundation Trust, University Hospital Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain.
Hospital Universitario Nuestra Señora de Candelaria · ESGuy's and St Thomas' NHS Foundation Trust · GBSpanish Clinical Research Network · ESUniversidad de La Laguna · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThere is still an undiscovered territory about the sequelae and lung ultrasound (LUS) findings after SARS-CoV2 acute infection. This study aims to investigate the post-COVID period from a clinical, psychosocial, and radiological point of view, analyze LUS on COVID-19 follow-up and detect whether these outcomes are related to the patient situation.

methodsWe conducted an observational study on patients diagnosed with SARS-CoV2 pneumonia and admitted to the University Hospital of La Candelaria (Tenerife, Spain) from 1st March to 31st August 2020. We performed a descriptive analysis on post-COVID manifestations, LUS score, health-related quality of life measured through the Euroqol 5D-5L questionnaire, and lung function parameters on follow-up, and we compared these variables to the outcomes during the hospital admission.

results77 patients were included; the mean age was 57 years and the follow-up mean time from hospital discharge was 16 weeks. 87% of the cases had symptoms on follow-up, the most common was dyspnea (65%); these manifestations were more frequent in females (p = 0,015). 76,5% of the cases had lung aeration alteration in LUS on follow-up; lower PaO2/FiO2 and greater CRP and IL-6 levels on admission were related to LUS score ≥1.

conclusionsAlmost 90% of the patients had persistent symptoms after 16 weeks of hospital discharge due to COVID-19, the most common manifestation presented was dyspnea. Altered lung aeration pattern in LUS was observed on more than 70% of the patients on follow-up.

Indexed as

COVID-19DyspneaFemaleHumansLungMiddle AgedQuality of LifeRNA, ViralSARS-CoV-2RNA, ViralCOVID-19Lung ultrasoundLUSPost-COVIDSARS-CoV2

Identifiers

PMID35870365
PMCPMC9299820
OpenAlexW4285992067

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.